Avantika’s portfolio of injectable products include diverse categories of molecules comprising of general injectables, oncology injectables and complex injectables. The dosage forms consist of solutions, suspensions and aseptic lyophilized powders in vial and PFS presentations. The complex injectable program includes difficult to formulate products such as microspheres, peptides, liposomal and nanotechnology driven products. These molecules in general require a high degree of characterization and structural sameness studies and in many cases, pharmacokinetic and patient-based clinical endpoint studies. Avantika has built dedicated state-of-the art, FDA-compliant sterile facilities to develop and manufacture these niche products.